Back
PTC Therapeutics Stock Predictions
Sponsored
PTCT
Sponsored
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
PTCT
PTC Therapeutics
Last Price:
50.29
Seasonality Move:
17.12%
7 Day Trial
ALL ACCESS PASS
$
7
Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.PTC Therapeutics Stock Forecast
- Over the next 52 weeks, PTC Therapeutics has on average historically risen by 35.1% based on the past 11 years of stock performance.
- PTC Therapeutics has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is PTC Therapeutics Stock Undervalued?
The current PTC Therapeutics [PTCT] share price is $50.29. The Score for PTCT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal. - PTCT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will PTC Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, PTC Therapeutics has on average historically risen by 35.1% based on the past 11 years of stock performance.
PTC Therapeutics Stock Rating
Buy
51
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics overpriced?
- PTC Therapeutics has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
PTC Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ptcbio.com
52-Week Data
52-Week High:
54.16
52-Week Low:
23.58
Prediction Charts
Market Cap:
3.88B
Price in USD:
50.29
Volume:
1.45M
Beta:
0.85
Technical Analysis
SMA50:
40.62
SMA100:
37.00
SMA200:
34.19
52-Wk Change:
109.63%
Stock Predictions
-
Is PTC Therapeutics stock public?
Yes, PTC Therapeutics is a publicly traded company. -
What is the PTC Therapeutics stock quote today?
The PTC Therapeutics stock price is 50.29 USD today. -
How to buy PTC Therapeutics stock online?
You can buy PTC Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-13 | 44.68 | 44.05 | 45.65 | 43.55 |
Nov-14 | 44.28 | 42.38 | 44.28 | 41.95 |
Nov-15 | 42.74 | 39.23 | 42.74 | 38.94 |
Nov-18 | 39.14 | 39.23 | 39.86 | 38.65 |
Nov-19 | 39.36 | 39.36 | 40.06 | 38.71 |
Nov-20 | 39.38 | 41.96 | 42.79 | 38.26 |
Nov-21 | 42.09 | 42.89 | 43.41 | 41.21 |
Nov-22 | 43.03 | 43.23 | 44.10 | 42.74 |
Nov-25 | 43.81 | 42.99 | 44.85 | 42.94 |
Nov-26 | 43.54 | 46.01 | 47.24 | 43.25 |
Nov-27 | 47.00 | 45.11 | 47.23 | 44.20 |
Nov-29 | 44.77 | 43.88 | 45.38 | 43.18 |
Dec-2 | 52.08 | 52.07 | 52.97 | 49.19 |
Dec-3 | 53.33 | 50.29 | 54.16 | 49.28 |
PTC Therapeutics Earnings
PTC Therapeutics Earnings Report: Per Share PTC Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
PTC Therapeutics Forecast Revenue Growth
PTC Therapeutics Stock Analysis: Historical quarterly revenues per share for PTC Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.82 per share.
* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.